Randomized, Controlled, Multi-center Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients with Retinopathy of Prematurity
Purpose of Study
To compare afibercept to laser therapy in babies who have Retinopathy of Prematurity (ROP).
Basic Eligibility Criteria
- Premature infant diagnosed with Retinopathy of Prematurity (ROP)
How to Contact Us
Principal Investigator: Faruk Orge, MD
Study Coordinator: Leslie Richards | 216-844-7934